These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Clinical Characteristics of Anti-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Antibodies in Chinese Patients with Idiopathic Inflammatory Myopathies. Ge Y; Lu X; Peng Q; Shu X; Wang G PLoS One; 2015; 10(10):e0141616. PubMed ID: 26509687 [TBL] [Abstract][Full Text] [Related]
11. Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure. Shovman O; Gilburd B; Chayat C; Lazar AD; Amital H; Blank M; Bentow C; Mahler M; Shoenfeld Y Immunol Res; 2017 Feb; 65(1):276-281. PubMed ID: 27618830 [TBL] [Abstract][Full Text] [Related]
12. [Screening of autoantibodies associated with necrotizing myopathy among undiagnosed chronic myopathy]. Kuru S; Suzuki S; Ogata K; Kobayashi M; Ishida C; Watanabe C; Matsumura T Rinsho Shinkeigaku; 2017 Oct; 57(10):562-566. PubMed ID: 28954975 [TBL] [Abstract][Full Text] [Related]
13. Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins. Lahaye C; Beaufrére AM; Boyer O; Drouot L; Soubrier M; Tournadre A Joint Bone Spine; 2014 Jan; 81(1):79-82. PubMed ID: 23953224 [TBL] [Abstract][Full Text] [Related]
14. Absence of Pathogenic Mutations and Strong Association With HLA-DRB1*11:01 in Statin-Naïve Early-Onset Anti-HMGCR Necrotizing Myopathy. Llansó L; Segarra-Casas A; Domínguez-González C; Malfatti E; Kapetanovic S; Rodríguez-Santiago B; de la Calle O; Blanco R; Dobrescu A; Nascimento-Osorio A; Paipa A; Hernandez-Lain A; Jou C; Mariscal A; González-Mera L; Arteche A; Lleixà C; Caballero-Ávila M; Carbayo Á; Vesperinas A; Querol L; Gallardo E; Olivé M Neurol Neuroimmunol Neuroinflamm; 2024 Sep; 11(5):e200285. PubMed ID: 39106428 [TBL] [Abstract][Full Text] [Related]
16. [Dermatomyositis-like syndrome revealing statin-induced necrotizing autoimmune myopathy with anti-HMGCR antibodies]. Merlant M; Fite C; Kottler D; Maisonobe L; Dossier A; Deschamps L; Descamps V Ann Dermatol Venereol; 2019 Sep; 146(8-9):550-556. PubMed ID: 30929872 [TBL] [Abstract][Full Text] [Related]
17. Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase in patients with immune-mediated myositis and necrotizing myopathy. Limaye V; Bundell C; Hollingsworth P; Rojana-Udomsart A; Mastaglia F; Blumbergs P; Lester S Muscle Nerve; 2015 Aug; 52(2):196-203. PubMed ID: 25521389 [TBL] [Abstract][Full Text] [Related]
18. Statins and myositis: the role of anti-HMGCR antibodies. Selva-O'Callaghan A; Alvarado-Cardenas M; Marin A; Pinal-Fernandez I Expert Rev Clin Immunol; 2015; 11(12):1277-9. PubMed ID: 26492593 [TBL] [Abstract][Full Text] [Related]
19. Spectrum of immune-mediated necrotizing myopathies and their treatments. Pinal-Fernandez I; Mammen AL Curr Opin Rheumatol; 2016 Nov; 28(6):619-24. PubMed ID: 27607340 [TBL] [Abstract][Full Text] [Related]
20. Screening for Anti-HMGCR Antibodies in a Large Single Myositis Center Reveals Infrequent Exposure to Statins and Diversiform Presentation of the Disease. Szczesny P; Barsotti S; Nennesmo I; Danielsson O; Dastmalchi M Front Immunol; 2022; 13():866701. PubMed ID: 35603214 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]